Publications & Presentations

Vectra Da

Publications & Presentations

Behavior of the Multi-Biomarker Disease Activity (Vectra® DA Algorithm) Score and Components in Patients with Rheumatoid Arthritis Treated with Tocilizumab

A Multi-Biomarker Disease Activity (Vectra® DA Algorithm)Score and Components Are Associated with Sustained Clinical Remission in Rheumatoid Arthritis: the REMIRA Study

Characterization of the Multi-Biomarker Disease Activity (Vectra® DA Algorithm) Score in a Subgroup of Patients from the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) Cohort Receiving Methotrexate.

Impact of Rheumatoid Arthritis Disease Activity Test on Clinical Practice

Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis

An Evaluation of Molecular and Clinical Remission in Rheumatoid Arthritis by Assessing Radiographic Progression

Impact of a multi-biomarker disease activity test on rheumatoid arthritis treatment decisions and therapy use

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis.

Validation of a novel multi-biomarker test to assess rheumatoid arthritis disease activity.

A Multi-Biomarker Disease Activity (Vectra DA Algorithm) Score Reflects Clinical Disease Activity and Tracks Responses in Patient with Rheumatoid Arthritis Treated with Either Adalimumab, Etanercept, and Infliximab.

©2018 Crescendo Bioscience, Inc. All rights reserved. Vectra, Crescendo Bioscience, MyRA and the associated logos are trademarks or registered trademarks of Crescendo Bioscience, Inc. in the United States and other jurisdictions.